Company
United StatesLupin Pharmaceuticals Inc., Baltimore, MD – FDA Inspections
Inspection records and compliance data for Lupin Pharmaceuticals Inc. in Baltimore, Maryland. 4 FDA inspections on record, last inspected May 23, 2014.
Company Profile
This profile covers Lupin Pharmaceuticals Inc. based in Baltimore, Maryland, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 2
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected February 27, 2009. Last inspected May 23, 2014.
Most cited issue areas
- Late submission of 15-day report2 inspections
- Late submission of quarterly safety reports1 inspection
- Timely submission1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 23, 2014 | VAI | Human Drugs · Bioresearch Monitoring | 880292 |
| December 23, 2011 | VAI | Human Drugs · Bioresearch Monitoring | 761230 |
| April 6, 2011 | NAI | Human Drugs · Drug Quality Assurance | 718224 |
| February 27, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 572735 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Lupin Pharmaceuticals Inc.
FEI Number
3004097115
Address
111 S Calvert St Fl 21st, Harborplace Tower, Baltimore, Maryland 21202, United States
Country
United States
ID: 5bd476cf-32c9-4a64-8d96-51320f27d83f